Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

NCT01660633 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)
OTHER: Autologous Transplantation

Sponsor

Acrotech Biopharma Inc.

Collaborators

[object Object]
[object Object]
[object Object]